DigestRedComo funciona
Red
/
Empresas
Ne
No verificado

NextPoint Therapeutics

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosOncología

4 Comunicados de prensa

Ver todos los comunicados de prensa
25/04/2025
Eventos
Industria
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
NextPoint Therapeutics to Showcase Pioneering Preclinical Data on NPX125, a Novel B7-H7 Targeted Antibody-Drug Conjugate (ADC) at AACR Annual Meeting 2025
Fuente
NextPoint Therapeutics
Editor
Business Wire
1.00
0
07/04/2025
Eventos
Industria
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
NextPoint Therapeutics to Highlight Antibody-Drug Conjugate (ADC) and T Cell Engager (TCE) Preclinical Findings Targeting Novel B7-H7 Pathway at AACR Annual Meeting
Fuente
NextPoint Therapeutics
Editor
Business Wire
1.00
0
07/11/2024
Eventos
Industria
Ciencia
Biotecnología
Farmacéutica
Oncología
Salud
VIH, SIDA y enfermedades autoinmunes
Medicina - Varios
NextPoint Therapeutics Announces Upcoming Poster Presentation on a B7-H7 Directed T Cell Engager Therapy at SITC2024
Fuente
NextPoint Therapeutics
Editor
Business Wire
1.00
0
05/09/2024
Industria
Biotecnología
Farmacéutica
Salud
Oncología
NextPoint Therapeutics Announces First-in-class T Cell Engager NPX372 As New Drug Candidate Targeting B7-H7 in Solid Tumors
Fuente
NextPoint Therapeutics
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0